811
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: Results from the PPP-Botnia Study

, , , , &
Pages 279-288 | Received 13 Sep 2010, Accepted 25 Nov 2010, Published online: 24 Jan 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Rui Yang, Lu Wang, Song Cao, Ming Chen, Chu-Jun Wu, Floyd Silva, Man-Jun Shen, Jin-Dong Chen, Mi-Mi Tang & Bi-Lian Liu. (2022) Sex difference in lipid levels in first-diagnosed drug-naïve depression patients: A case-control and 12-weeks follow-up study. The World Journal of Biological Psychiatry 23:3, pages 228-235.
Read now
Robin N. Groen, Nicolien C. de Clercq, Max Nieuwdorp, H. J. Rogier Hoenders & Albert K. Groen. (2018) Gut microbiota, metabolism and psychopathology: A critical review and novel perspectives. Critical Reviews in Clinical Laboratory Sciences 55:4, pages 283-293.
Read now
Antti-Jussi Pyykkönen, Bo Isomaa, Anu-Katriina Pesonen, Johan G. Eriksson, Leif Groop, Tiinamaija Tuomi & Katri Räikkönen. (2014) Sleep duration and insulin resistance in individuals without type 2 diabetes: The PPP-Botnia Study. Annals of Medicine 46:5, pages 324-329.
Read now

Articles from other publishers (25)

Karthik Sankar, Sushma Viswanathan, Uma maheswari mugundan, Roshini Kizhakkedeth Nazar, Saranya Ramasamy & Rajanandh Muhasaparur Ganesan. (2023) A systematic review of randomized controlled trials assessing the effect of Vortioxetine on metabolic syndrome risk indicators in patients with depression. Health Sciences Review 9, pages 100129.
Crossref
Zhongyu Tang, Yanping Zhen, Lin Zhang, Xuebing Liu & Jun Ma. (2023) Prevalence and factors associated with metabolic syndrome in first hospitalization for major depression disorder patients. Scientific Reports 13:1.
Crossref
Victor Mazereel, Johan Detraux, Davy Vancampfort, Ruud van Winkel & Marc De Hert. (2020) Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People With Serious Mental Illness. Frontiers in Endocrinology 11.
Crossref
Kayoko Isomura, Gustaf Brander, Zheng Chang, Ralf Kuja-Halkola, Christian Rück, Clara Hellner, Paul Lichtenstein, Henrik Larsson, David Mataix-Cols & Lorena Fernández de la Cruz. (2018) Metabolic and Cardiovascular Complications in Obsessive-Compulsive Disorder: A Total Population, Sibling Comparison Study With Long-Term Follow-up. Biological Psychiatry 84:5, pages 324-331.
Crossref
Vasiliki Mamakou, Ioanna Eleftheriadou, Anastasios Tentolouris, Nikolaos Sabanis, Aikaterini Drylli & Nikolaos Tentolouris. (2018) Diabetogenic Effects Associated with Psychiatric Treatment. Current Pharmacology Reports 4:2, pages 103-111.
Crossref
Georgina E. Crichton, Merrill F. Elias & Michael A. Robbins. (2016) Association between depressive symptoms, use of antidepressant medication and the metabolic syndrome: the Maine-Syracuse Study. BMC Public Health 16:1.
Crossref
Marine Azevedo Da Silva, Beverley Balkau, Ronan Roussel, Jean Tichet, Frédéric Fumeron, Guy Fagherazzi & Hermann Nabi. (2016) Longitudinal association of antidepressant medication use with metabolic syndrome: Results of a 9-year follow-up of the D.E.S.I.R. cohort study. Psychoneuroendocrinology 74, pages 34-45.
Crossref
H. Brochard, C. Boudebesse, C. Henry, O. Godin, M. Leboyer & B. Étain. (2016) Syndrome métabolique et troubles bipolaires : le sommeil est-il le chaînon manquant ?. L'Encéphale 42:6, pages 562-567.
Crossref
Sarah A. Hiles, Dóra Révész, Femke Lamers, Erik Giltay & Brenda W. J. H. Penninx. (2016) BIDIRECTIONAL PROSPECTIVE ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH DEPRESSION, ANXIETY, AND ANTIDEPRESSANT USE. Depression and Anxiety 33:8, pages 754-764.
Crossref
Katherine Samaras. 2016. Cardiovascular Diseases and Depression. Cardiovascular Diseases and Depression 305 331 .
Marine Azevedo Da SilvaAline DugravotBeverley BalkauRonan Roussel, Frédéric Fumeron, Alexis ElbazMarianne CanonicoArchana Singh-Manoux & Hermann Nabi. (2015) Antidepressant medication use and trajectories of fasting plasma glucose, glycated haemoglobin, β-cell function and insulin sensitivity: a 9-year longitudinal study of the D.E.S.I.R. cohort. International Journal of Epidemiology 44:6, pages 1927-1940.
Crossref
Bernhard T. Baune. 2015. Handbook of Psychocardiology. Handbook of Psychocardiology 1 20 .
Soyeon Park, Yeon Ho Joo, Roger S. McIntyre & Byungsu Kim. (2014) Metabolic Syndrome and Elevated C-Reactive Protein Levels in Elderly Patients With Newly Diagnosed Depression. Psychosomatics 55:6, pages 640-649.
Crossref
Nicole Vogelzangs, Hannie C. Comijs, Richard C. Oude Voshaar, Max L. Stek & Brenda W.J.H. Penninx. (2014) Late-life depression symptom profiles are differentially associated with immunometabolic functioning. Brain, Behavior, and Immunity 41, pages 109-115.
Crossref
Elizabeth Blanchard & Katherine Samaras. (2014) Double jeopardy: diabetes and severe mental illness. Addressing the special needs of this vulnerable group. Diabetes Management 4:4, pages 339-353.
Crossref
Nicole Vogelzangs, Aartjan TF Beekman, Arianne KB van Reedt Dortland, Robert A Schoevers, Erik J Giltay, Peter de Jonge & Brenda WJH Penninx. (2014) Inflammatory and Metabolic Dysregulation and the 2-Year Course of Depressive Disorders in Antidepressant Users. Neuropsychopharmacology 39:7, pages 1624-1634.
Crossref
Brenda WJH Penninx, Yuri Milaneschi, Femke Lamers & Nicole Vogelzangs. (2013) Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Medicine 11:1.
Crossref
Atsuko Sekita, Hisatomi Arima, Toshiharu Ninomiya, Tomoyuki Ohara, Yasufumi Doi, Yoichiro Hirakawa, Masayo Fukuhara, Jun Hata, Koji Yonemoto, Yukiko Ga, Takanari Kitazono, Shigenobu Kanba & Yutaka Kiyohara. (2013) Elevated depressive symptoms in metabolic syndrome in a general population of Japanese men: a cross-sectional study. BMC Public Health 13:1.
Crossref
Joana Nicolau & Lluís Masmiquel. (2013) Diabetes mellitus y trastorno depresivo, un mal binomio. Endocrinología y Nutrición 60:10, pages 583-589.
Crossref
Joana Nicolau & Lluís Masmiquel. (2013) Diabetes mellitus and depressive disorder, an undesirable association. Endocrinología y Nutrición (English Edition) 60:10, pages 583-589.
Crossref
Katharine BarnardRobert C. PevelerRichard I.G. Holt. (2013) Antidepressant Medication as a Risk Factor for Type 2 Diabetes and Impaired Glucose Regulation. Diabetes Care 36:10, pages 3337-3345.
Crossref
Ramin Mojtabai. (2013) Antidepressant use and glycemic control. Psychopharmacology 227:3, pages 467-477.
Crossref
Francesco Margari, Giuseppina Zagaria, Madia Lozupone, Francesco Minerva, Rossella Pisani, Giuseppe Palasciano, Adriana Pastore, Vincenzo Palmieri & Orlando Todarello. (2013) Metabolic Syndrome: Differences between Psychiatric and Internal Medicine Patients. The International Journal of Psychiatry in Medicine 45:3, pages 203-226.
Crossref
Junzo Watanabe, Yutaro Suzuki & Toshiyuki Someya. (2012) Lipid Effects of Psychiatric Medications. Current Atherosclerosis Reports 15:1.
Crossref
Antti-Jussi Pyykkönen, Bo Isomaa, Anu-Katriina Pesonen, Johan G. Eriksson, Leif Groop, Tiinamaija Tuomi & Katri Räikkönen. (2012) Subjective Sleep Complaints Are Associated With Insulin Resistance in Individuals Without Diabetes. Diabetes Care 35:11, pages 2271-2278.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.